NAOR

Decentralized Rapid RNA Diagnostic Solutions

Health Tech & Life Sciences
Non Active, Mar 2024 ceased to operate
Pre-Seed Haifa, Israel Founded 2020
Last updated 2026-06-18
Total raised
Stage
Pre-Seed
Founded
2020
Headcount
7
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

NAOR is a platform for rapid RNA diagnosis of COVID-19 and other pathogens. The company uses a one-step nucleic acid amplification method to multiply specific sequences of RNA, resulting in extremely high sensitivity and specificity. The technology enables high-volume lab-grade results in field settings such as airports, schools, and workplaces. The tests can also be conducted at home.

Originally developed at the Technion, the technology combines biochemistry, electronics, and artificial intelligence. The original clinical study (with results from Rambam Medical Center) was one of the first to use rapid RNA testing of the virus. The company has since gathered significant data from around the world and further developed the technology. Its platform is now available in select markets worldwide.

NAOR is developed by Rapid Diagnostic System Ltd.

Q&A

What is NAOR's primary focus?
NAOR is a platform that develops decentralized rapid RNA diagnostic solutions for COVID-19 and other pathogens.
What is the current status of NAOR?
NAOR is currently inactive, having ceased operations in March 2024.
When was NAOR founded?
NAOR was founded in July 2020.
How many employees did NAOR have?
NAOR had 7 employees, falling within the 1-10 employee bucket.
What technology does NAOR's platform utilize?
NAOR's platform combines biochemistry, electronics, and artificial intelligence for its rapid RNA diagnostic technology.
Where was NAOR's technology originally developed?
NAOR's technology was originally developed at the Technion.
What types of customers does NAOR target?
NAOR targets customers in education (K12), healthcare, and life sciences, including providers.
What business models does NAOR employ?
NAOR employs B2G, B2B2C, B2C, and B2B business models.

Team · 2

Oren Furest
Founder · Founder (No longer with the company)
Founder · Co-founder & CSO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
SensingArtificial Intelligence
Target customers
EducationK12 EducationHealthcare & Life SciencesHealthcareProviders
Business model
B2GB2B2CB2CB2B

Tags

airportsnon-invasivehome-careschoolsairlinesartificial-intelligencesensorsmonitoringaviationmedical-technologiesclinicsmedical-deviceshospitalsdiagnosticsdata-analyticsdigital-healthcare
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2020-7
Employees (exact)7
Status reasonNon Active, Mar 2024 ceased to operate